@Fatshark Sorry, no long winded write up coming from me! Agree...

@Fatshark Sorry, no long winded write up coming from me! Agree with your take, results from ANSTO are actually better than Core. Half the acid (and impurities reduced accordingly) only a minor hit on REE recovery with the heavies Dy+Tb being marginal. Reagents are the biggest input cost to these processes. I spoke with Rob about his take on the difference between results and he said ANSTO don't monitor the tests as often as Core so the acid was topped up less frequently = longer time running with less acid concentrations. Definitely bodes well for testing at higher pH (less acid) in Phase 2 work.

Also a big tick to have results confirmed by an independent world class lab.

I am going to wait for the Phase 2 results before revisiting my OPEX calcs, they are only a month or so away per this update. ARR's scoping study is keeping me entertained in the interim! Will benchmark against ARR shortly..